LUCIA KULHAVY: Open Payments
NPI 1225099773 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 47 payments from 18 companies in 2025. Trend: 2023 $805 · 2024 $2,174 · 2025 $1,771
Long term medical supply or device loan: $1,000Food & beverage: $740Education: $31
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $1,116 |
| PFIZER INC. | 5 | $108 |
| ABBVIE INC. | 4 | $94 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $57 |
| ACCORD HEALTHCARE, INC. | 2 | $45 |
| Eisai Inc. | 2 | $42 |
| Pharmacosmos Therapeutics Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
Products named: KISQALI, IBRANCE, TALVEY, Enhertu, PLUVICTO, Camcevi, Lenvima, MONOFERRIC.
Industry payments across VA — which companies pay providers there.
